Inovio Pharmaceuticals Inc. Stock Sheds 10.5%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. plunged 10.5% to $1.45 on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 5.5% to 24,315.00 and Dow Jones Industrial Average falling 3.4% to 51,523.06.

This was the stock's third consecutive day of losses.

Inovio Pharmaceuticals Inc. closed 46.7% below its 52-week high of $2.72, which the company achieved on December 17th.

The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 1.4% to $272.32, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. fell 2.96% to $29.88.

Trading volume totaled 15.0 million, compared to the 50-day average of 10.7 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

November 05, 2026 16:35 ET (21:35 GMT)